ANVS — Annovis Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $30.59m
- $20.04m
Annual cashflow statement for Annovis Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.46 | -14.5 | -25.3 | -56.2 | -24.6 |
| Non-Cash Items | 1.89 | 4.7 | 9.15 | 16.5 | 2.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.401 | 0.657 | -1.14 | -0.229 | 0.682 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -3.97 | -9.13 | -17.3 | -40 | -21.9 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 12 | 46.7 | 0.005 | 17.3 | 26.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.07 | 37.6 | -17.3 | -22.6 | 4.8 |